Status:
UNKNOWN
Screening for Masked Hypertension With Smart Wearable Devices (SMART)
Lead Sponsor:
Jing Liu
Collaborating Sponsors:
HUAWEI
Conditions:
Masked Hypertension
Eligibility:
All Genders
18-50 years
Brief Summary
In recent years, a large number of consumer-grade and Smart Wearable Devices (SWD) such as smart watches, with BP measurement property, have entered the market and have a high configuration and utiliz...
Detailed Description
Masked hypertension (MH) is defined as elevated ambulatory or home blood pressure (BP), but normal office BP, often complicated with severe cardiovascular and renal damage. MH is easily missed and nee...
Eligibility Criteria
Inclusion
- 18-50 years of age, male or female
- No clear previous history of hypertension and other cardiovascular diseases
- Signed informed consent form
Exclusion
- Patients with established hypertension
- History of severe heart, liver, or kidney disease
- Inability to cooperate in completing the study
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05409898
Start Date
July 1 2022
End Date
July 1 2024
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, China, 100044